NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00281918,Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia,https://clinicaltrials.gov/study/NCT00281918,CLL-8,COMPLETED,"This randomized phase III trial is studying fludarabine, cyclophosphamide, and rituximab to see how well they work compared to fludarabine and cyclophosphamide in treating patients with B-cell chronic lymphocytic leukemia.",YES,Leukemia,DRUG: Rituximab|DRUG: Cyclophosphamide|DRUG: Fludarabine Phosphate,"Progression-free Survival (PFS), Progression-free survival (PFS) was defined as the time between randomization and the date of first documented disease progression, relapse or death by any cause, whichever came first., Median observation time at time of analysis was approximately 21 months|Final Analysis: Time to Progression-free Survival Event, Progression-free survival was defined as the time between randomization and the date of first documented disease progression, relapse or death by any cause, whichever came first., Median observation time was approximately 66.4 months","Event-free Survival (EFS), Event-free survival (EFS) was defined as the time between randomization and the date of disease progression, relapse, start of new CLL treatment or death by any cause., Median observation time at time of analysis was approximately 21 months|Overall Survival (OS), Overall survival (OS) was defined as the time between randomization and the date of death due to any cause. Median OS was not reached., Median observation time at time of analysis was approximately 21 months|Disease-free Survival (DFS) of Patients With Confirmed Complete Response (CR)., CR is defined by at least 8 weeks of: 1)Absence of lymphadenopathy 2)No hepatomegaly or splenomegaly 3)Absence of B-symptoms 4)Normal blood count 5)Bone marrow aspirate and biopsy 8 weeks after the clinical and laboratory results demonstrated that a CR was achieved. A marrow sample had to be normocellular for age with less than 30% lymphocytes. Lymphoid nodules had to be absent. If marrow was hypocellular,a repeat biopsy was taken 4 weeks later and samples were re-reviewed in conjunction with the prior pathology. DFS was calculated from time of CR to relapse or death. Median DFS was not reached., Median observation time at time of analysis was approximately 21 months|Final Analysis: Time to Overall Survival Event, Overall survival (OS) was defined as the time between randomization and the date of death due to any cause., Median observation time was approximately 66.4 months|Final Analysis: Time to Event-free Survival Event, Event-free survival was defined as the time between randomization and the date of disease progression, relapse, start of new Chronic Lymphocytic Leukemia treatment or death by any cause., Median observation time was approximately 66.4 months|Final Analysis: Time to Disease-free Survival (DFS) Event in Participants With Complete Response (CR), CR is defined by at least 8 weeks of: 1)Absence of lymphadenopathy 2)No hepatomegaly or splenomegaly 3)Absence of B-symptoms 4)Normal blood count 5)Bone marrow aspirate and biopsy 8 weeks after the clinical and laboratory results demonstrated that a CR was achieved. A marrow sample had to be normocellular for age with less than 30% lymphocytes. Lymphoid nodules had to be absent. If marrow was hypocellular,a repeat biopsy was taken 4 weeks later and samples were re-reviewed in conjunction with the prior pathology. DFS was calculated from time of CR to relapse or death, Median observation time was approximately 66.4 months|Final Analysis: Duration of Response, Duration of response was defined as the time from the first documented Complete Response, Partial Response to disease progression or death by any cause., Median observation time was approximately 66.4 months|Final Analysis: Percentage of Participants With Complete Response (CR) and Partial Response, CR is defined by at least 8 weeks of: 1)Absence of lymphadenopathy 2)No hepatomegaly or splenomegaly 3)Absence of B-symptoms 4)Normal blood count 5)Bone marrow aspirate and biopsy 8 weeks after the clinical and laboratory results demonstrated that a CR was achieved. A marrow sample had to be normocellular for age with less than 30% lymphocytes. Lymphoid nodules had to be absent. If marrow was hypocellular,a repeat biopsy was taken 4 weeks later and samples were re-reviewed in conjunction with the prior pathology. Partial response is defined as a decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment., Median observation time was approximately 66.4 months|Final Analysis: Time to New Treatment for Chronic Lymphocytic Leukemia(CLL), The time from randomization to the start of a new treatment., Median observation time was approximately 66.4 months",,Hoffmann-La Roche,German CLL Study Group,ALL,"ADULT, OLDER_ADULT",PHASE3,817,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,CDR0000454560|GCLLSG-CLL-8|EU-20560|ML17102,2003-07,2007-07,2011-10,2006-01-25,2011-03-29,2013-09-19,"Gosford Hospital, Gosford, New South Wales, 2250, Australia|Westmead Institute for Cancer Research at Westmead Hospital, Westmead - Wentworthville, New South Wales, 2145, Australia|Royal Brisbane and Women's Hospital, Brisbane, Queensland, 4029, Australia|Princess Alexandra Hospital, Brisbane, Queensland, 4102, Australia|Peter MacCallum Cancer Centre, East Melbourne, Victoria, 3002, Australia|Frankston Hospital, Frankston, Victoria, 3199, Australia|Hanuschkrankenhaus, Vienna, A-1140, Austria|Rudolfinerhaus, Vienna, A-1190, Austria|Allg. Krankenhaus der Stadt Wien Universitaets-Kinderklinik, Wien, 1090, Austria|AZ Sint-Jan, Brugge, 8000, Belgium|Institut Jules Bordet, Brussels, 1000, Belgium|Cliniques Universitaires Saint-Luc, Brussels, 1200, Belgium|Universitair Ziekenhuis Antwerpen, Edegem, B-2650, Belgium|U.Z. Gasthuisberg, Leuven, B-3000, Belgium|Clinique Universitaire De Mont-Godinne, Mont-Godinne Yvoir, 5530, Belgium|Masaryk University Hospital, Brno, 62500, Czech Republic|Fakultni Nemocnice Hradec Kralove, Hradec Kralove, 50005, Czech Republic|University Hospital - Olomouc, Olomouc, 775 20, Czech Republic|University Hospital in Pilsen - Lochotin, Pilsen-Lochotin, 30460, Czech Republic|First Medical Clinic of Charles University Hospital, Prague, 128 08, Czech Republic|Copenhagen County Herlev University Hospital, Copenhagen, DK-2730, Denmark|Vejle Sygehus, Vejle, DK-7100, Denmark|Hopital Louis Pasteur, Colmar, 68024, France|Hopital Andre Mignot, Le Chesnay, 78157, France|Centre Leon Berard, Lyon, 69373, France|Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes, Marseille, 13273, France|Centre Hospitalier Universitaire de Rennes, Rennes, 35033, France|Institut de Cancerologie de la Loire, Saint Priest en Jarez, 42270, France|Praxis Fur Hamatologie und Onkologie Ahaus, Ahaus, 48683, Germany|Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie, Ansbach, 91522, Germany|Hamatologische/Onkologische Gemeinschaftspraxis - Augsburg, Augsburg, 86150, Germany|Klinikum Augsburg, Augsburg, DOH-86156, Germany|Humaine - Clinic, Bad Saarow, 15526, Germany|Internistische Praxis - Bayreuth, Bayreuth, 95448, Germany|Internistische Gemeinschaftspraxis - Berlin, Berlin, 13347, Germany|Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin, D-12200, Germany|Onkologische Schwerpunktpraxis Bielefeld, Bielefeld, D-33602, Germany|Krankenhaus Bietigheim, Bietigheim, D-74321, Germany|Augusta-Kranken-Anstalt gGmbH, Bochum, D-44791, Germany|Marienhospital Bottrop gGmbH, Bottrop, D-46236, Germany|DIAKO Ev. Diakonie Krankenhaus gGmbH, Bremen, D-28239, Germany|Krankenhaus Burglengenfeld, Burglengenfeld, D-93133, Germany|Onkologische Schwerpunktpraxis at Facharzt fuer Innere Medizin, Coesfeld, 48653, Germany|Praxis Fuer Haematologie Internistische Onkologie, Cologne, D-50677, Germany|Medizinische Universitaetsklinik I at the University of Cologne, Cologne, D-50924, Germany|Onkologische Schwerpunktpraxis, Cottbus, D-03046, Germany|Onkologische Gemeinschaftspraxis - Dresden, Dresden, 01127, Germany|Universitaetsklinikum Duesseldorf, Duesseldorf, D-40225, Germany|Internistische Praxis - Dusseldorf, Dusseldorf, 40211, Germany|Florence-Nightingale-Krankenhause, Deaconess Kaiserswerth, Dusseldorf, 40489, Germany|Krankenhaus Benrath, Dusseldorf, 40593, Germany|St. Georg Klinikum Eisenach GmbH, Eisenach, 99817, Germany|Helios Klinikum Erfurt, Erfurt, 99012, Germany|Internistiche Praxis, Erfurt, 99084, Germany|Onkologische Schwerpunkt Praxis, Erlangen, D-91052, Germany|St. Antonius Hospital, Eschweiler, DOH-52249, Germany|Universitaetsklinikum Essen, Essen, D-45122, Germany|Evangelisches Krankenhaus Essen Werden, Essen, D-45239, Germany|Staedtische Kliniken Esslingen, Esslingen, D-73730, Germany|Internistische Gemeinschaftspraxis - Forchheim, Forchheim, 91301, Germany|Klinikum Frankfurt (Oder) GmbH, Frankfurt (Oder), D-15236, Germany|Staedtische Kliniken Frankfurt am Main - Hoechst, Frankfurt, D-65929, Germany|Gemeinschaftspraxis - Freiburg, Freiburg, 79098, Germany|Klinikum Garmisch - Partenkirchen GmbH, Garmisch-Partenkirchen, D-82467, Germany|Internistische Praxis - Gerlingen, Gerlingen, 70839, Germany|Gemeinschaftspraxis Fuer Innere Medizin, Hematologie Und Onkologie, Giessen, 35392, Germany|Universitaetsklinikum Goettingen, Goettingen, D-37075, Germany|Klinik Fuer Innere Medizin, Hematology/Oncology, Ernst Moritz Armdt Universitaet, Greifswald, D-17475, Germany|St. Marien Hospital - Katholisches Krankenhaus Hagen gGmbH, Hagen, D-58095, Germany|Internistische Praxis - Halle, Halle, 06108, Germany|Universitaetsklinikum Halle, Halle, D-06120, Germany|Asklepios Klinik St. Georg, Hamburg, D-20099, Germany|University Medical Center Hamburg - Eppendorf, Hamburg, D-20246, Germany|St. Marien-Hospital Hamm - Klinik Knappenstrasse, Hamm, D-59071, Germany|Evangelische Krankenhaus Hamm, Hamm, DOH-59063, Germany|Krankenhaus Siloah - Medizinische Klinik II, Hannover, D-30449, Germany|Universitatsklinikum Heidelberg, Heidelberg, D-69115, Germany|Marienhospital at Ruhr University Bochum, Herne, D-44625, Germany|Privatklinik Dr. R. Schindlbeck GmbH & Co. KG, Herrsching, D-82211, Germany|Universitaetsklinikum des Saarlandes, Homburg, D-66424, Germany|Clinic for Bone Marrow Transplantation and Hematology and Oncology, Idar-Oberstein, D-55743, Germany|Gemeinschaftspraxis Innere Medizin, Jena, D-07743, Germany|Staedtisches Klinikum Karlsruhe gGmbH, Karlsruhe, 76133, Germany|St. Vincentius-Kliniken, Karlsruhe, D-76137, Germany|Internistische Gemeinschaftspraxis - Kassel, Kassel, D-34117, Germany|Klinikum Kempten Oberallgaeu, Kempten, D-87439, Germany|Internistische Praxis - Kiel, Kiel, 24105, Germany|University Hospital Schleswig-Holstein - Kiel Campus, Kiel, D-24116, Germany|Praxis fuer Haematologie und Onkologie, Koblenz, D-56068, Germany|Stiftungsklinikum Mittelrhein - Gesundheitszentrum Evangelisches Stift Sankt Martin Koblenz gGmbH, Koblez, D-56068, Germany|Internistische Onkologische Praxis - Kronach, Kronach, 96317, Germany|Klinikum Landshut, Landshut, 84034, Germany|Onkologische Schwerpunktpraxis - Leer, Leer, D-26789, Germany|Klinikum ""St. Georg"" Leipzig, Leipzig, D-04126, Germany|Klinikum Lippe - Lemgo, Lemgo, D-32657, Germany|Internistische Praxis - Loerrach, Loerrach, D-79539, Germany|Gemeinschaftspraxis - Ludwigshafen, Ludwigshafen, 67061, Germany|Sana Kliniken Luebeck, Luebeck, 23560, Germany|Internistische Gemeinschaftspraxis - Magdeburg, Magdeburg, D-39104, Germany|Staedtisches Klinikum Magdeburg - Altstadt, Magdeburg, D-39104, Germany|Universitaetsklinkum Magdeburg der Otto-von-Guericke-Universitaet Magdeburg, Magdeburg, D-39120, Germany|Universitatsklinik Mainz, Mainz, D-55101, Germany|III Medizinische Klinik Mannheim, Mannheim, D-68305, Germany|Krankenhaus Maria Hilf GmbH, Moenchengladbach, D-41063, Germany|Hamatologie/Onkologie Praxisgemeinschaft - Muenchen, Muenchen, D-81241, Germany|University of Muenster, Muenster, D-48129, Germany|Haematologisch - Onkologische Gemeinschaftspraxis, Muenster, D-48149, Germany|Klinikum der Universitaet Muenchen - Grosshadern Campus, Munich, D-81377, Germany|Staedtisches Krankenhaus Muenchen - Harlaching, Munich, D-81545, Germany|Klinikum Rechts Der Isar - Technische Universitaet Muenchen, Munich, D-81675, Germany|Haematologische Schwerpunktpraxis, Munich, D-81679, Germany|Onkologische Schwerpunktpraxis Dr. Schmidt, Neunkirchen, D-66538, Germany|Praxis fuer Haematologie und Interne Onkologie, Norderstedt, 22844, Germany|Klinikum Nuernberg - Klinikum Nord, Nuernberg, D-90419, Germany|Gemeinschaftspraxis - Oberhausen, Oberhausen, D-46045, Germany|Internistische Gemeinschaftspraxis - Offenbach, Offenbach, D-63065, Germany|Internistische Gemeinschaftspraxis - Oldenburg, Oldenburg, D-26121, Germany|Klinikum Oldenburg, Oldenburg, D-26133, Germany|Asklepios Klinik Pasewalk, Pasewalk, 17309, Germany|Municipal Hospital Complex, Pforzheim, D-75178, Germany|Klinikum Ernst Von Bergmann, Potsdam, D-14467, Germany|Elisabeth Krankenhaus, Recklinghausen, 45661, Germany|Krankenhaus Barmherzige Brueder Regensburg, Regensburg, D-93049, Germany|Klinik und Poliklinik fuer Innere Medizin - Universitaet Rostock, Rostock, D-18055, Germany|Caritasklinik St. Theresia, Saarbrucken, D-66113, Germany|Nordwestkrankenhaus Sanderbusch, Sanderbusch, 26452, Germany|St. Marien - Krankenhaus Siegen GMBH, Siegen, D-57072, Germany|Internistische Gemeinschaftspraxis - Stuttgart, Stuttgart, 70176, Germany|Haematologische Praxis, Stuttgart, D-70173, Germany|Klinik fuer Onkologie - Katharinenhospital Stuttgart, Stuttgart, D-70174, Germany|Diakonie Klinikum Stuttgart, Stuttgart, D-70176, Germany|Marienhospital Stuttgart, Stuttgart, D-70199, Germany|KKH Torgau, Torgau, 04860, Germany|Onkologische Gemeinschaftspraxis - Trier, Trier, 54290, Germany|Krankenanstalt Mutterhaus der Borromaerinnen, Trier, D-54219, Germany|Praxis Fuer Internistische Haematologie / Onkologie, Troisdorf, 53840, Germany|Universitaetsklinikum Tuebingen, Tuebingen, D-72076, Germany|Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm, Ulm, D-89081, Germany|Municipal Hospital Complex, Villingen-Schwenningen, D-78045, Germany|Praxis fur Innere Medizin - Wanzleben, Wanzleben, 39164, Germany|Haematologische Praxis, Weiden, D-92637, Germany|Schwerpunktpraxis Hamatologie/Onkologie - Wesel, Wesel, 46483, Germany|Dr. Horst-Schmidt-Kliniken, Wiesbaden, D-65199, Germany|Medizinische Klinik und Poliklinik II - Universitaetsklinikum Wuerzburg, Wuerzburg, D-97080, Germany|Kliniken St. Antonius, Wuppertal 2, D-42283, Germany|Hamatologisch - Onkologische Praxis Wurzburg, Wurzburg, 97070, Germany|Soroka University Medical Center, Beer-Sheva, 84101, Israel|BNAI Zion Medical Center, Haifa, 31048, Israel|Rambam Medical Center, Haifa, 31096, Israel|Hadassah University Hospital, Jerusalem, 91120, Israel|Riverview Cancer Care Medical Associates, PC, Kfar Saba, 44281, Israel|Kaplan Hospital, Rehovot, 76100, Israel|Ospedale Oncologico A. Businco, Cagliari, 09121, Italy|Fondazione Centro San Raffaele Del Monte Tabor, Milano, 20132, Italy|Perugia Regional Cancer Center, Perugia, 06122, Italy|Ospedale Sant' Eugenio, Rome, 00144, Italy|Policlinico A. Gemelli - Universita Cattolica del Sacro Cuore, Rome, 00168, Italy|Auckland City Hospital, Auckland, 1, New Zealand|Canterbury Health Laboratories, Christchurch, New Zealand|Palmerston North Hospital, Palmerston North, New Zealand|Hospital General Universitario Morales Meseguer, Murcia, 30008, Spain|Hospital Virgen Del La Salud, Toledo, 45004, Spain",
